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Summary
Rapid and accurate identification of communities at highest risk of morbidity from schistosomiasis
is key for sustainable control. Although school questionnaires can effectively and inexpensively
identify communities with a high prevalence of Schistosoma haematobium, parasitological
screening remains the preferred option for S. mansoni. To help reduce screening costs, we
investigated the validity of Lot Quality Assurance Sampling (LQAS) in classifying schools
according categories of S. mansoni prevalence in Uganda, and explored its applicability and cost-
effectiveness. First, we evaluated several sampling plans using computer simulation and then field
tested one sampling plan in 34 schools in Uganda. Finally, cost-effectiveness of different
screening and control strategies (including mass treatment without prior screening) was
determined, and sensitivity analysis undertaken to assess the effect of infection levels and
treatment costs. In identifying schools with prevalence ≥50%, computer simulations showed that
LQAS had high levels of sensitivity and specificity (>90%) at sample sizes <20. The method also
provides an ability to classify communities into three prevalence categories. Field testing showed
that LQAS where 15 children were sampled had excellent diagnostic performance (sensitivity:
100%, specificity: 96.4%, positive predictive value: 85.7% and negative predictive value: 92.3%).
Screening using LQAS was more cost-effective than mass treating all schools (US$ 218 vs. US$
482 / high prevalence school treated). Threshold analysis indicated that parasitological screening
and mass treatment would become equivalent for settings where prevalence exceeds 50% in 75%
of schools and for treatment costs of US$ 0.19 per schoolchild. We conclude that, in Uganda,
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LQAS provides a rapid, valid, and cost-effective method for guiding decision makers in allocating
finite resources for the control of schistosomiasis.
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Introduction
Renewed commitment to morbidity control of schistosomiasis provides an important
opportunity to re-evaluate and improve control strategies to ensure both cost-effectiveness
and long-term sustainability (Utzinger et al., 2003). One key issue for the planning of
control is the rapid and accurate identification of high risk communities requiring mass
treatment with praziquantel. The use of morbidity questionnaires is well established as an
effective and inexpensive means of identifying communities with a high prevalence of
Schistosoma haematobium (Lengeler et al., 2002). By contrast, the use of questionnaires for
S. mansoni has proved less promising, and parasitological diagnosis remains the preferred
option. However, parasitological screening of individuals incurs significant expenses
associated with staff allowances, capital equipment, transport and materials to collect and
process faecal samples and as such, there is a need to collect reliable data as rapidly and
cheaply as possible.
Parasitological surveys of schools and communities usually rely upon classical statistical
approaches (Bennett et al., 1991). Here, sample sizes are fixed in advance of data-collection
according to the expected levels of prevalence and the degree of precision required,
modified by logistics and resource constraints. Classical analysis such as estimation or
hypothesis testing is then performed on the collected data. For example, current WHO
recommendations are based on the concept of sample surveys of 50 children per school
within defined ecological zones (Montresor et al., 1998). This sample size was selected
because it was considered to be the maximum number of children that a survey team could
sample and examine in a single day. Such an approach typically involves a survey team of
several staff moving with a single vehicle, and necessitates entry and analysis of survey
data. It is therefore often considered to be prohibitively expensive for a national programme
to sustain parasitological surveys on a large scale where this approach is used.
An alternative sampling approach is Lot Quality Assurance Sampling (LQAS) in which the
sample size is not fixed in advance (Lemeshow & Taber, 1991). Instead, observations are
collected individually or in small batches and, after each observation, the data are examined
to see whether or not a decision, such as whether to intervene, may be made from the
accumulated data. LQAS combines data-collection and data-analysis into a single process or
sampling plan. This approach can considerably reduce the sample size requirements as well
as the data-processing overheads of a survey. LQAS methods are best used in situations
where classification (e.g. into prevalence classes) of a population or community is useful
and where the emphasis is on decision making (e.g. whether or not to intervene in a
particular community) rather than estimation of prevalence and intensity of infection. The
use of LQAS has increased in the health field over the last 15 years and has been used to
monitor vaccination coverage (Lanata et al., 1990; Sandford. 1993; Singh et al., 1996;
Tawfik et al., 2001), HIV prevalence (Houinato et al., 2002) and leprosy elimination (Gupte
et al., 2004), and to guide control of lymphatic filariasis (Lakshmi, 2000), malaria
(Rabarijaona et al., 2001) and trachoma (Myatt et al., 2003).
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LQAS has recently been used to identify communities in Madagascar with high prevalence
of S. mansoni (Rabarijaona et al., 2003). Given the potential importance this approach has
for national control programmes, there is a requirement for evaluating its usefulness in other
settings. Importantly, there is also a need to assess the cost-effectiveness of the approach in
comparison to both traditional sampling approaches and to mass treatment without prior
screening. To date, studies have only investigated the cost-effectiveness of alternative
screening strategies in delivering treatment for S. haematobium at the community level
(Talaat & Evans, 1996; Ansell & Guyatt, 2002), and for S. haematobium (Guyatt et al.,
1994) and S. mansoni (Carabin et al., 2000) at the individual level. The cost-effectiveness of
screening and treatment strategies at the community level has yet to be evaluated for S.
mansoni. The aim of the present study was to assess the validity of LQAS in classifying
schools according categories of prevalence of S. mansoni in Uganda, and to explore its
applicability and cost-effectiveness in guiding national control efforts.
Methods
Study area and control programme
The study was conducted in the context of a national schistosomiasis and soil-transmitted
control programme in Uganda (Kabatereine et al., 2005). This programme was established in
2002 with support from the Schistosomiasis Control Initiative, funded by the Bill and
Melinda Gates Foundation. Following WHO guidelines, the programme is classifying
communities according to three strategies: (1) in communities with a high prevalence
(≥50%) schoolchildren are treated every year and high risk groups, such as fishermen, are
treated; (2) in communities with a moderate prevalence (≥20% and <50%) schoolchildren
are treated once every two years; and (3) in communities with a low prevalence (<20%)
chemotherapy should be available in health facilities for treatment of suspected cases.
Because of the widespread distribution of soil-transmitted helminthes (STH) in Uganda,
albendazole is co-administered with praziquantel.
The geography and epidemiology of S. mansoni in Uganda has recently been reported by
Kabatereine et al. (2004). This work shows that no transmission typically occurs in areas
where total annual rainfall was <850 mm and altitude was >1400 m. These areas were,
therefore, set aside without the need for further surveys. It was also shown that prevalence
consistently exceeded 50% in areas within 5km of Lakes Victoria and Albert, and thus in
these areas all communities could be justified, with relative certainty, to warrant mass
treatment without the need for further surveys. Outside these two ecological areas, where
smaller rivers and water bodies are numerous, it is suggested that individual communities
are surveyed using parasitological methods (Brooker et al., 2004a). It is in these areas that
the LQAS method will be implemented if it is shown to be a reliable, quick and cost-
effective method to classify communities according to treatment categories.
Binomial LQAS method
An overview of the method is provided by Maytt et al. (2003). In brief, LQAS is used to test
the null hypothesis (H0) that the proportion of individuals (P) infected with S. mansoni is
lower than some critical level (PT) according to the requirements for treatment
classifications: if P<PT then H0 is accepted and no action is required; if P≥PT then H0 is
rejected and mass treatment of the population is required. The first objective here is to
classify schools according to different prevalence thresholds: 20% and 50% since, as
mentioned above, these represent prevalence thresholds which warrant different treatment
schedules.
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LQAS data are collected and analysed using a sampling plan that specifies a maximum
sample size (n) and the number of cases (d) allowed in the sample (so-called lots) before a
classification of a community having a high prevalence is made. Here, schools are
considered as lots and d represents the number of children found to be infected with S.
mansoni. A series of sampling plans were developed to select a maximum sample size (n)
and the number of cases (d) that are allowed in the sample of n subjects before deciding that
a community is a high prevalence community. The combination of maximum sample size
(n) and number of defects (d) forms the stopping rules of the sampling plan. Sampling stops
when either the maximum sample size (n) is met or the allowable number of cases (d) is
exceeded: if d is exceeded then the community is classified as high prevalence and an
intervention required; if n is met without d being exceeded then the community is classified
as low prevalence and an intervention not required. The values of n and d used in a sampling
plan depend upon the threshold values used in the classification system and the acceptable
levels of risk (Lemeshow & Taber, 1991).
Using LQAS to provide a granular classification scheme
Ordinarily, LQAS provides a binary classification system. A finer classification system may
be provided by applying alternative, secondary sampling plans to data already collected and
classified, by previously applied sampling plans, as coming from low (<50%) prevalence
communities (see Myatt et al. (2003) for a recent application to trachoma). This approach
starts by collecting data using a primary sampling plan to classify populations into two
groups: (1) schools with prevalences likely to be less than 50%, and (2) schools with
prevalences likely to be greater than or equal to 50%, based on n and an initial d, termed d1.
The secondary sampling is applied to the samples already taken from the populations not
classified as high prevalence by the primary sampling plan on the basis of a second d,
termed d2. The secondary sampling plan is designed to classify populations into two groups:
(1) schools with low prevalences likely to be less than 20%, and (2) schools with moderate
prevalences likely to be greater than or equal to 20% but <50%. Thus, a three class
classification scheme may be implemented using two sampling plans.
Computer simulations of the LQAS method
The LQAS method was initially tested using computer-based simulations, implemented in
the R language for data analysis and graphics (Ihaka & Gentleman, 1996), using country-
wide data from previous, conventional school surveys of schistosomiasis in Uganda
(Kabatereine et al., 2004). In all, 13,800 children in 202 schools were sampled. The
simulations used one-thousand with-replacement simple random samples from each of the
sampled schools (i.e., each school in a dataset was surveyed 1000 times). Thus, a total of
202,000 LQAS surveys were simulated for each of the primary sampling plans tested. The
use of simple random sampling in the simulations means that the simulations are indicative
of how well the simulated LQAS sampling plans are likely to perform when an equal
probability selection method (EPSeM) sampling method is used to collect data. EPSeM
sampling of children in schools is not difficult since a random or systematic sample of
children from school registers may be used. Values for the primary (n, d1) and secondary (n,
d2) sampling plans were chosen by performing an exhaustive search of cumulative binomial
probabilities for combinations of n and d that provide acceptable levels of risk (Lemeshow
& Taber, 1991).
The results of the primary sampling plan are presented graphically using (1) an operating
characteristic (OC) curve, and (2) an average sample size (ASN) curve (Lemeshow & Taber,
1991). An OC curve summarises the probability of making a decision not to intervene at
different levels of prevalence. The probability of making a decision to intervene is the
complement of the OC function. The complement of the OC function (i.e. 1 - OC) is more
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intuitive than the OC function since it summarises the probability of making a decision to
intervene at different levels of prevalence. An ASN curve shows the sample size required to
make a classification using the primary sampling plan by the true prevalence in the school
being sampled. The average sample size needed to make a decision varies with prevalence,
allowing decisions to be made in high prevalence communities with relatively small sample
sizes. Each combination of n and d1 generates a single OC curve and a single ASN curve.
The validity of the primary sampling plans was evaluated by comparing the true prevalence
in each school, as assessed by the conventional (reference) survey method and its prevalence
classification as returned by the LQAS method. Diagnostic performance was assessed in
terms of sensitivity (the percentage of high prevalence correctly classified as such as by the
LQAS method) and specificity (the percentage of low prevalence schools correctly classified
as such by the LQAS method). Negative predictive value (NPV) is the proportion of
communities classified as low prevalence communities that are true low prevalence
communities. Positive predictive value (PPV) is the proportion of communities classified as
high prevalence communities that are true high prevalence communities. In this context,
PPV is a measure of appropriate resource utilisation. The results of the simulations of
applying the secondary sampling plan are summarised graphically using a classification plot
which plots the range of true prevalences for each classification. The agreement between
true prevalence classes and the classifications made using the two sampling plans were
calculated and assessed using the Kappa statistic: values of Kappa less than 0.4 indicate poor
agreement, values between 0.4-0.75 suggest good agreement, and values above 0.75,
excellent agreement. Gross misclassification errors are defined as true low prevalence
schools classified as high prevalence by LQAS and true high prevalence schools classified
as low prevalence by LQAS.
Field testing
In 2004, field trials were conducted to assess the validity of the selected sampling plans for
classifying schools by the prevalence of S. mansoni in 12 schools of Kigandalo Subcounty,
Mayuge District along the shores of Lake Victoria and 22 schools in Pakwach and Panyimur
subcounties, Nebbi District along the Albert Nile. In Nebbi District, a single round of
school-based treatment has been undertaken in 2003 whereas no treatment had previously
been undertaken in Mayuge District. Survey teams consisted of a driver, a parasitologist and
a technician. Ethical clearance was obtained from the Ministry of Health, Uganda and
Imperial College, London. It was decided to evaluate a sampling plan of n=15, d1=7, d2=2
using the conventional method of sampling. Here, 15 children (as defined by the sampling
plan) from class 4 were selected using a random number table and asked to provide stool
samples. Subsequently, a survey of 50 children from class 4 (whether or not they had been
initially selected) were asked to provide a stool sample, which was processed using the
Kato-Katz method and examined using a compound microscope at × 100 magnification.
These data were used to evaluate the validity of the LQAS method. The trials also provided
information on the operational aspects and time taken to complete each LQAS sampling
plan in order to estimate the cost-effectiveness of alternative screening approaches.
Microscopic examination of 50 randomly selected schoolchildren using the compound
microscope was considered the gold standard for determining treatment strategy, and
estimates of sensitivity, specificity, PPV and NPV were calculated. Estimates of PPV and
NPV were used in the cost-effectiveness analysis.
Costs and cost-effectiveness
The cost of each sampling strategy was calculated using an itemized-menu approach,
whereby costs are calculated according to unit price and quantities used (Guyatt, 1998).
Following this approach, items are divided into personnel, capital and consumables. Only
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the financial cost to the programme was assessed. Capital costs were assumed to last five
years and were annualized using a discount rate of 3% and expressed in dollars (Drummond
et al., 1997). All other costs were paid in local currency and their current values were
converted into equivalent US$ using the 2003 mid-year exchange rates of Ugandan Shillings
1,943 to US$1. Estimates of quantities were based on fieldwork of the applicability of the
LQAS method. The mean treatment dose per child was estimated from treatment registers
from the 2003 treatment round.
Cost-effectiveness was assessed in terms of cost per high (≥50%) prevalence school treated
based on the different screening and treatment criteria. Costs of screening individual schools
and treating according to prevalence categories was compared to the costs of mass treatment
of all schools in an entire hypothetical subcounty of 34 schools and 23,188 schoolchildren
(based on the average number of schools in a subcounty and the average school enrolment).
Using the strategy of mass treating every school, there is 100% sensitivity in identifying
high prevalence schools – however the risk that low prevalence schools will inappropriately
receive mass treatment (i.e. false positive) is significant. Following parasitological screening
(using either LQAS or conventional sampling method), schools are assumed to receive
treatment according to the classification provided by the sampling method. These
classifications may be successful or not according to the PPV and NPV of LQAS relative to
the conventional approach. The values of PPV and NPV are taken from the field validation
studies. The financial costs of drug treatment using praziquantel and albendazole were
calculated using the ingredient approach and were based on preliminary cost analysis of the
control programme in 14 schools in Nebbi District in 2003; no treatment had been
implemented in Mayuge District. Screening and treatment costs were estimated for one year.
The cost implications are considered from a perspective of the control programme.
One way sensitivity analysis was undertaken to investigate the effect of the proportions of
schools with prevalence ≥50% and of cost per child treated on the cost-effectiveness of the
alternative sampling methods compared to a mass treatment strategy, assuming the delivery
costs remain constant. Threshold analysis was undertaken to determine the critical values
central to cost-effectiveness.
Results
Computer simulations
Eleven sampling plans were evaluated (Table 1). With all sampling plans, LQAS provides
the ability to identify communities with a high prevalence of S. mansoni with high levels of
sensitivity and specificity, even at very small maximum sample sizes. For example, the
sampling plans with a maximum sample size of eight had a sensitivity of 95.2% and a
specificity of 95.0%. In contrast, sampling plans with such small maximum sample sizes had
low positive predictive values in the test populations. Sampling plans with larger maximum
sample sizes had slightly higher sensitivities and specificities and considerably better
positive predictive values.
LQAS also provides an ability to classify communities into more than two prevalence
categories. Performance of sampling plans with very small maximum sample sizes had low
proportions of correct classification but made few gross classification errors (i.e. high
prevalence communities being classified as low prevalence communities and vice-versa).
Sampling plans with larger maximum sample sizes provided higher proportions of correct
classification and made no gross classification errors. For the purposes of identifying
communities with high prevalences of S. mansoni, sampling plans with small maximum
sample sizes may be used when moderate levels of positive predictive values are acceptable.
For finer classifications, sampling plans with moderate maximum sample sizes (i.e. n ≥ 15)
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provide acceptable proportions of correct classification coupled with extremely low
probabilities of making gross classification errors.
Following a consideration of logistics and cost, it was decided by the control programme to
evaluate a sampling plans of n=15, d1=7, d2=2 in the field. The OC curve from the
simulations and the ASN curve for the primary (n=15, d1=7) sampling plan and the sample
size needed to make a classification in each simulation by prevalence is shown in Figure 1.
This shows that the probability of deciding to intervene is zero at low prevalences (<20%)
and one at very high prevalences (>80%) and increases both smoothly and rapidly around a
critical prevalence. The average sample size needed to make a decision decreases with
increasing prevalence. This allows classifications to be made in high prevalence
communities with relatively small sample sizes and reduce the time required to conduct the
survey. The results of the simulations of applying the secondary sampling plan are
summarised graphically in Figure 2 which presents a classification plot which plots the
range of true prevalences for each classification. This confirms Table 1 and shows that a
most schools were correctly classified by LQAS according to their true prevalence category:
97.6% of low prevalence schools; 63.0% of moderate; and 88.5% of high. From 202,000
simulations, only five low prevalence schools were grossly incorrectly classified as high
prevalence and 14 high prevalence schools classified as low prevalence (Figure 2).
Field testing of the n=15, d1=7, d2=2 sampling plan
A total of 1,687 schoolchildren aged 8-14 years from 34 schools were included in the
exhaustive parasitological survey. The overall prevalence of infection was 28.0%; 31.2% in
schools in Mayuge District and 26.2% in schools in Nebbi District (Table 2). In both
districts combined, 18 schools were classified as low prevalence, 10 as moderate prevalence,
and 6 as high prevalence.
Overall, the ability of the sampling plan to discriminate between <50% and ≥50% had a
sensitivity of 100%, a specificity of 96.4%, a PPV of 85.7% and a NPV of 92.3%. The
observed agreement between true prevalence and the classifications (low, moderate and
high) made with the sampling plan are shown in Table 2. The overall observed agreement
between true prevalence and the classification made by the two sampling plans (d1=7, d2=2)
was 76.5% (Kappa=0.615). The level of agreement for schools classified as low, moderate
and high prevalence was 77.8%, 60% and 100%, respectively. Importantly, no high
prevalence schools were grossly misclassified as low prevalence or vice-versa. Table 2
indicates that LQAS had better diagnostic performance in Mayuge schools than in Nebbi
schools.
Operational aspects
The field studies found that in a single day six LQAS surveys and two conventional surveys
could be completed. All of the technicians took great interest in the LQAS method and
encountered no problems in its use. They had no doubt that they would be able to use the
approach for targeting treatment, especially since they saw the obvious benefits of LQAS
over conventional sampling approaches.
Costs and cost-effectiveness
The itemized financial costs of the LQAS and conventional sampling plans are summarized
in Table 3, which shows that the total financial costs were US$ 20.04 per school for LQAS
and US$ 56.20 per school for conventional sampling. The financial saving of LQAS was
due principally to lower per diem and reduced drug costs from wastage. During 2003, the
control programme had treated 38,052 individuals (12,185 schoolchildren and 25,867
community members) in Nebbi District. The estimated financial cost per schoolchild treated
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in 14 schools was US$ 0.29 for both praziquantel and albendazole, where 70.1% of total
costs were delivery costs (Table 4).
The costs and cost-effectiveness of alternative screening and treatment strategies for a single
subcounty on a yearly basis are presented in Table 5. The most expensive option is mass
treatment of all schools without prior parasitological screening. In this approach, 23,188
schoolchildren would have been treated at a total cost of US$6,725. The most cost-effective
option was parasitological screening using LQAS, where only 8,184 children are treated (US
$218/high prevalence school treated, assuming 41% of schools have prevalence >50% and a
PPV of 86%). Assuming a PPV of 67-100%, as found respectively in Nebbi and Mayuge
districts, the equivalent cost ratio is US$ 246-176.
The effect of varying proportions of schools with a high prevalence (here defined as ≥50%)
on the cost-effectiveness of parasitological screening relative to mass treatment of all
schools is shown in Figure 3. As expected, the cost-effectiveness of mass treatment is
inversely and non-linearly related to the proportion of schools with a high prevalence. Only
when over 75% of schools have prevalence ≥50% does screening using LQAS become less
cost-effective compared to mass treatment. In practice, 41% of schools in Kigandalo
subcounty Mayuge (where no treatment had previously been undertaken) had prevalence
≥50% and nationally 21.4% of schools surveyed by Kabatereine et al. (2004) had a
prevalence ≥50%.
Assuming 41% of schools have prevalence ≥50%, the effect of varying cost per schoolchild
treated is shown in Figure 4. Mass treatment is only cost-effective relative to screening using
LQAS for a treatment cost per schoolchild of less than US$ 0.19; the current cost per
schoolchild treated by the Uganda programme is estimated to be US$ 0.29.
Discussion
This study has investigated the validity, applicability and cost-effectiveness of LQAS as a
rapid assessment method for targeting mass treatment with praziquantel for the control of
schistosomiasis as implemented by the Uganda National Schistosomiasis Control
Programme. Mass treatment is currently provided to all schools in known or suspected high-
risk subcounties. One of the consequences of delivering mass treatment to all schools within
subcounties identified as at risk is that low prevalence schools will inappropriately receive
mass treatment and this may waste drug and other resources. Consequently, mass treatment
is not necessarily more cost-effective than screening of individual schools. Especially where
high prevalence communities are highly localised within an area, there is a possibility that
the cost of treating schools which do not require treatment outweighs the cost of
parasitological screening of individual schools. The results presented here show that LQAS
is a simple, rapid, reliable and cost-effective approach to guide decision makers in allocating
finite resources for the control of schistosomiasis.
We demonstrate that LQAS has particular value in classifying schools in Uganda by
treatment strategies according to the categories of infection prevalence: <20%, 20-49% and
≥50%. The LQAS approach requires a much smaller sample size than conventional
sampling approach as currently proposed (Montresor et al., 1998). In the present study, a
sampling plan of n=15, d1=7 reliably classified schools into high (≥50%) and low
prevalence (<50%). An earlier study showed that a LQAS sampling plan of n=16, d1=6
provided the optimal sampling plan for identifying high S. mansoni prevalence (>50%)
schools in endemic areas of Madagascar (Rabarijaona et al., 2003). Here, we have extended
such a binary classification method to provide a finer classification system as is required by
the national control programme in Uganda. In particular, schools identified as high
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prevalence by the first sampling plan are classified as high prevalence, schools identified as
high prevalence by the second sampling plan are classified as moderate prevalence, the
remaining schools are classified as low prevalence. The use of LQAS to provide a three-
class classification system has reliably been used to classify communities according to the
prevalence of active trachoma in Malawi (Myatt et al., 2003).
The reason that two settings were selected for field testing was to evaluate LQAS in
different transmission settings in Uganda, and also in areas where control had not previously
been implemented (Mayuge District) and where a single round of mass treatment had been
provided in 2003 (Nebbi District). Sensitivity was 100% in both settings. However,
specificity and the performance of the secondary sampling plan were poorer in Nebbi
District. This is suggested to be due to the lower intensities of infection in Nebbi District as
a consequence of previous treatment (Table 2). Notwithstanding these differences, it is
argued that LQAS is a reliable method in both pre- and post-treatment settings. Its
performance after multiple rounds of treatment is an issue for further investigation.
In implementing LQAS, we propose that parasitological screening takes place only in areas
of potential schistosomiasis risk. To help identify areas of potential S. mansoni risk, the
national programme has been using geographical information systems (GIS) and remote
sensing (RS) as geographic decision making tools for determining large-scale patterns of
infection for guiding control and help exclude areas where S. mansoni risk is unlikely to be
prevalent on the basis of rainfall and altitude (Kabatereine et al., 2004). We have earlier
demonstrated that a GIS/RS approach could be of particular value in excluding areas where
S. haematobium is unlikely to be prevalent in Tanzania, and so help focus on priority areas
where school questionnaire surveys should be undertaken to more precisely target control
(Brooker et al. 2001a, 2002).
The selection of a screening approach relies not only on its diagnostic reliability but also on
its costs and cost-effectiveness. For S. haematobium, using self-reported schistosomiasis and
self-reported blood in urine to identify high-prevalence schools for mass treatment has been
shown to be more cost-effective than parasitological diagnosis using urine filtration (Ansell
& Guyatt, 2002). This study conducted in Tanzania found that the cost/infected child treated
was US$ 1.33 for the questionnaire approach and US$ 2.30 for the urine filtration approach,
and only 8% of the infected children would not have been treated. Using symptoms to
identify schools with a high S. mansoni prevalence has been shown to be less reliable
(Brooker et al., 2001b; Lengeler et al., 2000; Utzinger et al., 2000). In terms of cost-
effectiveness, Carabin et al. (2000) found that screening all individuals using a Kato-Katz
smear and treating only the ones found to be infected was more cost-effective than treating
all symptomatic patients presenting at Primary Health Care Centres (PHCCs) in Burundi.
The present study is the first to assess the cost-effectiveness of parasitological screening to
identify high-prevalence schools for mass treatment.
It should be noted that the estimates of cost-effectiveness are used for illustrative purposes
and not meant to comprehensively estimate the overall cost-effectiveness for a specific
national control programme. Nonetheless, our sensitivity analysis showed that
parasitological screening using the LQAS method would remain cost-effective relative to
mass treatment for settings where the percentage of schools with prevalences of 75% or
above and for cost per treatment below US$ 0.18. Similar results for treatment costs were
obtained in the study from Burundi where providing treatment on the basis of symptoms of
individuals presenting at PHCCs would only be more cost-effective than parasitological
screening for a drug price per treatment of less than US$ 0.21 (Carabin et al., 2000).
However, although treatment costs may fall below these thresholds, it is extremely unlikely
that a given area would have more than 75% of schools having a high prevalence. For
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example, based on national survey data, it is estimated that 5% of schools in Cameroon
(Ratard et al., 1990), and that 8.8% of schools in Mali (Gryseels, 1989) have prevalence
>50%. These data accord with the known geographical focality of schistosomiasis, and
emphasize that the cost-effectiveness of screening is principally determined by the
epidemiology and geography of infection rather than treatment costs.
Our economic analysis is based on a single screening of schools at the start of the control
programme. In practice however screening may be undertaken every two years to assess the
impact of the control programme in reducing the proportion of schools requiring mass
treatment (see Brooker et al. (2004b) for a discussion of the assessment of programme
impact). Such an approach would result in even more cost savings since high prevalence
schools would become low prevalence schools and no longer necessitate mass treatment.
However, it is worth stressing that economic factors alone should not guide treatment
strategies. There may be value for mass treating all schools in a given subcounty to help
mobilize the community, but thereafter parasitological screening may be used to guide
treatment strategies
We can conclude that, in Uganda, LQAS may provide national programme managers with a
valid, straightforward and cost-effective method with which to assess the distribution of S.
mansoni and hence ensure that treatment is targeted cost-effectively. Full programmatic
implementation of the LQAS method will require evaluation of the method in other endemic
S. mansoni areas. National programmes currently being implemented in Burkina Faso, Mali,
Niger, Tanzania and Zambia, with support from the Schistosomiasis Control Initiative,
provide an ideal opportunity to assess the usefulness of LQAS as a rapid assessment tool for
S. mansoni. As indicated above, the cost-effectiveness of the approach will depend on the
epidemiology and geography of infection and as such, the relative cost-effectiveness may
differ in other countries. Rapid mapping methods are already implemented for assessing the
distribution of onchocerciasis (Noma et al., 2002), and for assessing the distribution of Loa
loa and hence which communities are at high risk of severe adverse reaction following drug
treatment for onchocerciasis (Addiss et al., 2003). As well as improving our understanding
of the distribution of S. mansoni, data collected through the LQAS method may also prove
useful in assessing treatment coverage, akin to the widespread use of LQAS to monitor
vaccination coverage.
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Figure 1.
(a) Probability of classifying school as having prevalence 50% or greater by prevalence, and
(b) sample size required to make classifications in each simulation by prevalence for the
sampling plan of n=15, d1=7 based on 202,000 simulated surveys.
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Figure 2.
Box plot of true proportion infected by classification scheme (low, moderate and high) for a
sampling plan of n=15, d1=7, d2=2 based on 202,000 simulated surveys. The horizontal line
within each box represents the median; the lower and upper bounds of the box correspond to
the 25- and 75 percentiles; the whiskers correspond to the range of non-outlying data. Width
of boxes is proportional to the number in each category. Upper dashed line represents the
50% prevalence threshold and lower dashed line the 20% prevalence threshold.
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Figure 3.
Cost-effectiveness of screening using LQAS relative to mass treatment of all schools
without prior screening in a hypothetical population of 23,188 schoolchildren in 34 schools
on a yearly basis as a function of the proportion of schools having a prevalence of 50% or
greater.
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Figure 4.
The effect of different costs per child treated on the cost-effectiveness of the LQAS method
to screen schools and provide treatment according to low and high prevalence categories
relative to a mass treatment approach in a hypothetical population of 23,188 schoolchildren
in 34 schools on a yearly basis, where 21.4% of schools are assumed to have prevalence
≥50%.
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Table 2
Prevalence, mean sample sizes and diagnostic performance of primary and secondary sampling plans in
schools in Mayuge District and Nebbi District, Uganda to assess the validity of the LQAS method to estimate
treatment strategies, 2004.
Mayuge Nebbi Both
No. children sampled 616 1071 1687
Mean sample size per school
(in reference survey)
51.3 48.9 49.6
Prevalence of S. mansoni
(range by school)
31.2
(2-84)
26.2
(8-67)
28.0
(2-84)
Mean intensity of infection
(epg, 95% confidence interval)
244.3
(197.7-290.2)
37.9
(27.0-48.2)
103.1
(86.6-120.1)
Primary plan1
  Sensitivity (%) 100 100 100
  Specificity (%) 100 95.0 96.4
  PPV (%)2 100 66.7 85.7
  NPV (%) 100 100 100
Secondary plan3,4
  Low 85.7 72.7 77.8
  Moderate 100 55.6 60.0
  High 100 100 100
  All 91.7 68.2 76.5
1Used to classify schools into <50% and ≥50%.
2
PPV = Positive Predictive Value, NPV = Negative Predictive Value
3Used to classify schools into three prevalence classes: low (<20%), moderate (≥20% and <50%) and high (≥50%).
4
The percentage of schools correctly classified in each prevalence class by LQAS according to true prevalence estimated from conventional
sampling.
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Table 4
Cost of school-based delivery of praziquantel and albendazole in 14 schools in Nebbi District, Uganda in
2003. (Breakdown by item is available from the corresponding author.)
Cost area Cost (US$) % of total
Sensitization and awareness 89.35 2.5
Teacher training 433.10 12.2
Registration 309.57 8.7
Drug distribution 189.63 5.4
Drug treatment 2,478.53 70.1
Health education material 37.96 1.1
Total 3,538.14 100
Cost per schoolchild treated 0.29
Delivery cost per schoolchild treated 0.09
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Table 5
Comparison of annual total costs and the numbers treated according to different screening and control
strategies in a hypothetical subcounty of 23,188 children in 34 schools, Uganda. It is assumed that 41% of
schools have prevalence <50% and therefore would warrant mass treatment, and that the PPV of LQAS is
86%.
LQAS survey Conventional
survey
Mass treatment
Total costs (US$) 3,055 4,680 6,725
Costs associated with
  Screening (%of total) 681 (22.3) 1,911 (40.8) 0 (0)
  Drug (%of total) 1,637 (53.6) 1,910 (40.8) 4,638 (69.0)
  Other (%of total) 737 (24.1) 859 (18.4) 2,087 (31.0)
Estimated no. children treated 8,184 9,548 23,188
Estimated no. schools mass treated 12 14 34
Cost per high prev. school treated (US$) 218 334 482
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